AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint
AstraZeneca has announced positive top-line results of the phase IV ASCENT trial for Tudorza Pressair (aclidinium bromide 400 µg, twice-daily), a long-acting muscarinic antagonist...
One reason clinical trials for Alzheimer’s disease have failed — And the digital biomarker that could help address that
Introducing a new disease-modifying therapy, from research through to launch, is an extremely complex process, with lengthy and expensive drug development cycles. While clinical...
Ultragenyx and Kyowa Kirin Announce Positive 48-Week Data from Adult Phase 3 Study of Burosumab in X-Linked Hypophosphatemia
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, Kyowa Hakko Kirin Co.,...
ViiV Healthcare begins phase III study of long-acting cabotegravir for HIV prevention in women
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced the start of HPTN...
Takeda Pharma begins phase 1 trial of Zika vaccine candidate, TAK-426
Takeda Pharmaceutical Company Limited has announced that its purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate (TAK-426) has progressed into a phase 1 clinical...
InDex Pharmaceuticals Reports New Mechanism of Action Data for Cobitolimod
InDex Pharmaceuticals Holding AB (publ) today announced new scientific data on the mechanism of action of cobitolimod, the company's lead drug candidate. The findings...
Merck, Pfizer announce phase III JAVELIN Gastric 300 trial in patients with pre-treated advanced gastric cancer fails to meet primary endpoint
Merck and Pfizer have announced that the phase III JAVELIN Gastric 300 trial did not meet its primary endpoint of superior overall survival (OS)...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...
